[New observations on the correlations between hyperuricemic diathesis and arterial pathology: the place of uric acid eliminator medications in the treatment of arteriopathies of the extremities].
D001162:Arteriosclerosis Obliterans; D004198:Disease Susceptibility; D006801:Humans; D011339:Probenecid; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D014527:Uric Acid; D015049:Zoxazolamine
D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D014527:Uric Acid; D015049:Zoxazolamine; D011339:Probenecid
ARTERIOSCLEROSIS OBLITERANS; PROBENECID; SULFONAMIDES; URIC ACID; ZOXAZOLAMINE